NorthWest Biotherapeutics Inc (NWBO)

[Chiugray]

Well said Flipper.

Along the same lines of appreciating the depth of NWBO's accomplishments during the last several years in EU (2014 revenue in German, 2015 revenue in UK coming), I would add / emphasize:

- even with lots of money, not many other companies could accomplish what NWBO management has accomplished during the same time frame. Not all CEOs have the vision to invest the time and money in the EU when time and money was so scarce for a small company like NWBO.
- even while operating on a shoestring budget and staff, NWBO has done what other companies could not. DCVAX-L is the "first" to get hospital exemption in Germany and for UK, the first product selected for the first step of a two-step process to receive early patient access likely in 2015, which leads to revenues.

One can question NWBO's actions as a shareholder regarding individual financings, contracts, mfg partners, decisions, and timing, but my overall gut check is whether the ratio of accomplishment, time spent, money used, and value generated is good or bad.

- accomplishment - start of revenues Q4 2014 (wow!), DCVAX-D and L looking strong.
- time spent - guessing 3-5 years on EU effort (given how hard it is as demonstrate by how other companies do not take this effort on, this is also a wow)
- money used / dilution - 60M shares outstanding is not bad (CLDX is at 89M OS shares, IMUC also 60M OS)
- value generated - time will tell on the stock price but it is low currently. However I say this is likely due to illegal naked shorting and other nefarious manipulation tactics.

So far I am very happy with the management team and their progress. If I were in the future where NWBO did ultimately provide a cure for cancer, and I was looking back, how could such a world changing accomplishment be done smoothly without all the challenges we are facing today.